ADXS : Insider Transactions for Advaxis Inc | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Advaxis Inc (ADXS)

$0.06 0.00 (0.00%) as of 4:30 Fri 6/3

Download

Exchange:

OTC Bulletin Board

Security Type:

Common

Shares Out:

66,230,000

Market Cap:

4.11(M)

Last Volume:

362,100

Avg Vol:

361,089

52 Week Range:

$0.062 - $0.062

Level I Sector:

N/A

Level II Sector:

N/A

Level III Sector:

N/A

Member Indexes:

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -


6 Months 1 Year 2 Year

Company Profile Advaxis is a clinical-stage biotechnology company focused on the development and commercialization of proprietary Listeria monocytogenes (Lm) Technology antigen delivery products based on a platform technology that utilizes live attenuated Lm bioengineered to secrete antigen/adjuvant fusion proteins. Co.'s pipeline of product candidates include: ADXS-503, which is for the cancer indication of non-small cell lung cancer in combination with KEYTRUDA® (pembrolizumab); ADXS-504, which is for the cancer indication of early stage prostate cancer; and ADXS-PSA, which is for the cancer indication of metastatic prostate cancer in combination with KEYTRUDA® (pembrolizumab).

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	1,317,716	1,317,716
Total Buy Value	$0	$0	$0	$0
Total People Bought	0	0	1	1
Total Buy Transactions	0	0	1	1
Total Shares Sold	0	0	0	0
Total Sell Value	$0	$0	$0	$0
Total People Sold	0	0	0	0
Total Sell Transactions	0	0	0	0
End Date	2024-02-01	2023-10-31	2023-05-02	2022-05-02

Adjust Filter Settings

Records found: 465

Page 3 of 19

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

Chief Scientific Officer

• – –

2017-11-02

4

S

$3.19

$40,274

D/D

(12,625)

224,640

-

Lombardo Anthony A

Interim CEO

• – –

2017-11-02

4

S

$3.19

$77

D/D

(24)

92,935

-

Chief Financial Officer

• – –

2017-11-02

4

S

$3.19

$40,621

D/D

(12,734)

231,770

-

Chief Scientific Officer

• – –

2017-10-31

4

A

$3.40

$1,469

D/D

432

237,265

-

Chief Financial Officer

• – –

2017-10-31

4

A

$3.40

$1,289

D/D

379

244,504

-

10% Owner

– – •

2017-10-11

4

S

$4.30

$2,580,000

I/I

(600,000)

4,100,043

-

Chief Scientific Officer

• – –

2017-09-29

4

A

$4.18

$2,136

D/D

511

236,833

-

Chief Financial Officer

• – –

2017-09-29

4

A

$4.18

$1,768

D/D

423

244,125

-

10% Owner

– – •

2017-09-26

4

S

$4.00

$1,200,000

I/I

(300,000)

4,700,043

-

10% Owner

– – •

2017-09-25

4

S

$4.38

$1,775,315

I/I

(405,323)

5,000,043

-

10% Owner

– – •

2017-09-22

4

S

$4.68

$2,499,120

I/I

(534,000)

5,405,366

-

Chief Financial Officer

• – –

2017-07-31

4

A

$6.47

$1,812

D/D

280

243,429

-

Chief Scientific Officer

• – –

2017-07-31

4

A

$6.47

$2,167

D/D

335

236,004

-

O'connor Daniel

Chief Executive Officer

• • –

2017-06-30

4

A

$6.49

$4,816

D/D

742

618,352

-

Chief Financial Officer

• – –

2017-06-30

4

A

$6.49

$2,557

D/D

394

243,149

-

Chief Scientific Officer

• – –

2017-06-30

4

A

$6.49

$3,096

D/D

477

235,669

-

O'connor Daniel

Chief Executive Officer

• • –

2017-06-19

4

A

$0.00

$0

D/D

177,102

617,610

-

Chief Scientific Officer

• – –

2017-06-19

4

A

$0.00

$0

D/D

57,199

235,192

-

Chief Financial Officer

• – –

2017-06-19

4

A

$0.00

$0

D/D

57,199

242,755

-

Chief Financial Officer

• – –

2017-05-31

4

A

$8.07

$1,767

D/D

219

185,556

-

Chief Scientific Officer

• – –

2017-05-31

4

A

$8.07

$2,139

D/D

265

177,993

-

O'connor Daniel

Chief Executive Officer

• • –

2017-05-31

4

A

$8.07

$3,397

D/D

421

440,508

-

Chief Scientific Officer

• – –

2017-05-01

4

A

$0.00

$0

D/D

57,881

177,728

-

O'connor Daniel

Chief Executive Officer

• • –

2017-05-01

4

A

$0.00

$0

D/D

142,996

440,087

-

Chief Financial Officer

• – –

2017-05-01

4

A

$0.00

$0

D/D

57,881

185,337

-

465 Records found	1 2 3 4 5 6 7 8 9 Next	Page 3 of 19

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.